1 Teaspoon in Your Morning Coffee Stops Insulin Resistance (within minutes)

DeLauer describes a second mechanism that emerges at higher doses, referencing a study in the American Journal of Clinical Nutrition. Where the fasting protocol uses cinnamon to mimic insulin, the high-dose meal protocol exploits cinnamon's ability to increase GLP-1, an incretin hormone that delays gastric emptying. He draws a loose parallel to Ozempic, clarifying that cinnamon is not a receptor agonist but rather increases natural GLP-1 levels. This leads to food staying in the stomach longer, delaying carbohydrate absorption and extending the feeling of fullness. He personally incorporates this by adding 3 teaspoons to a satiety-focused protein shake. The practical advice is to mix the cinnamon directly into the meal—oatmeal, yogurt, or a shake—so that it co-travels through the GI tract. He acknowledges that the 6-teaspoon dose is extreme and primarily for research context, recommending most people stay at 3 teaspoons to balance benefit and coumarin risk.

DeLauer cites a 2022 meta-analysis in the Journal of Food Biochemistry showing that 2–3 grams of cinnamon daily led to about 1.5 lb weight loss over a couple of weeks. He attributes the effect primarily to appetite suppression—cinnamon moderates insulin, reducing hunger, and the GLP-1 component enhances satiety, causing people to eat less. However, he then dives into a more provocative mechanistic layer: cinnamaldehyde's ability to uncouple mitochondria in fat cells, as demonstrated in University of Michigan rodent and cell culture studies. This uncoupling causes energy to be released as heat instead of being stored, effectively burning fat via thermogenesis. While the human data does not directly prove thermogenesis, DeLauer triangulates the animal data (cinnamon prevented obesity in overfed rodents) and the cell data to suggest that the small weight loss seen is not solely from eating less. He notes that for fat loss specifically, a dose closer to 2 teaspoons may be more beneficial, though any time of day works.

DeLauer presents this as an additional metabolic benefit rather than a primary protocol. A 2022 meta-analysis demonstrated that daily cinnamon consumption reduced LDL by 6 mg/dL and triglycerides by 9 mg/dL. He explains the mechanism in accessible language: AMPK activation suppresses anabolic pathways, so the liver makes less new fat (decreased lipogenesis). Simultaneously, LDL receptor activity increases, meaning more LDL particles are recognized and cleared from the bloodstream. He uses the analogy of boats docking at a dock—more receptor docks mean fewer particles circulating. This is especially relevant because insulin resistance often elevates triglycerides, and improved insulin sensitivity from cinnamon further contributes to triglyceride lowering. The speaker does not specify a separate dose for lipid benefits; the general 1–2 teaspoons used for other purposes should suffice.

This is a personal protocol that DeLauer employs. He distinguishes between two reasons he uses protein shakes: fast absorption for muscle building after workouts, or prolonged satiety for meal replacement. For satiety, he chooses Sun Warrior Active Protein, a plant-based blend that already contains fiber, probiotics, digestive enzymes, and minerals. He adds 3 teaspoons of cinnamon, a dose that heavily activates the gastric emptying delay via GLP-1, turning a liquid shake into a slow-digesting, filling meal. He notes that chocolate protein and cinnamon taste great together, making the high dose palatable. He speculates that protein brands are missing an opportunity by not formulating cinnamon into satiety blends. This protocol is a hybrid of the high-dose gastric emptying protocol and a specific food matrix he endorses.

DeLauer briefly touches on studies showing that cinnamon consumption reduces malondialdehyde (MDA), a marker of lipid peroxidation, and elevates glutathione and superoxide dismutase—two major intracellular antioxidants. He frames this as important for insulin resistance because oxidative stress impairs insulin receptor signaling and damages pancreatic beta cells. By bolstering antioxidant defenses, cinnamon may help maintain cellular responsiveness to insulin and protect the liver from oxidative insults. Although this section of the video is shorter, the underlying mechanism reinforces the overall anti-insulin-resistance argument. He does not specify a separate dose; the standard 1–2 teaspoons used for glucose or weight benefits should confer the antioxidant advantages.

DeLauer cites a study in the American Journal of Clinical Nutrition where subjects consuming 3–6 teaspoons of cinnamon experienced a notable delay in gastric emptying. He clarifies that cinnamon is not a GLP-1 receptor agonist but increases endogenous GLP-1, which in turn slows stomach emptying and reduces the speed of carbohydrate absorption. This effect blunts the post-meal blood sugar spike and prolongs satiety. The dose is substantially higher than the insulin-mimetic dose, and he recommends consuming it with meals—mixed into yogurt, oatmeal, or a protein shake—so that the cinnamon co-traels with food through the digestive tract. He explicitly draws a comparison to 'osimpic' (Ozempic) but stresses that the mechanism is incretin-based, not receptor activation. Because of coumarin concerns, he advises not to regularly exceed 3–4 teaspoons for prolonged periods and to monitor tolerance.

DeLauer references a 2017 University of Michigan study on rodent and cultured human fat cells, where cinnamaldehyde—the compound responsible for cinnamon's flavor—increased uncoupling proteins, leading to fat cell thermogenesis. This process, known as mitochondrial uncoupling, dissipates the proton gradient as heat instead of producing ATP, effectively burning extra energy. He presents this as the most plausible mechanistic explanation for why overfed rodents given cinnamon gained less weight and for the 1.5 lb weight loss over weeks seen in human meta-analyses. He cautions that the evidence is from cell and animal studies and not a direct human clinical proof of thermogenesis, but it aligns with the overall metabolic improvements seen. This uncoupling effect adds a fat-burning dimension to cinnamon's benefits, separate from its satiety and insulin-related actions.

DeLauer elaborates on the 2024 meta-analysis that found cinnamon reduced HOMA-IR, meaning cells become more responsive to insulin, lowering the amount of insulin needed to clear glucose. Separately, a 2022 meta-analysis showed an LDL drop of 6 mg/dL and triglyceride drop of 9 mg/dL. He explains the lipid mechanism in detail: cinnamon increases AMPK, which curbs hepatic lipogenesis—the liver's production of fat—and upregulates LDL receptor activity. He uses a boat-docking analogy: LDL particles are like boats that need to dock at receptors to be cleared from the blood; when receptor number or affinity increases, more LDL is removed. This dual action may be particularly valuable for those with metabolic syndrome. He underscores that these are adjunctive effects and not a replacement for medical therapy, but they add to the case for daily cinnamon use.

DeLauer notes that studies have shown cinnamon reduces malondialdehyde (MDA), a marker of lipid peroxidation, and boosts glutathione and superoxide dismutase, two critical antioxidant defense enzymes. He connects this to insulin resistance, explaining that when cells are under oxidative stress, insulin signaling is impaired. By lowering oxidative load, cinnamon may help restore normal cellular function and insulin sensitivity. This effect also dovetails with his earlier point about liver health, because glutathione is vital for hepatic detoxification. He doesn't specify a protocol purely for antioxidant purposes but frames it as an added benefit when consuming cinnamon for glucose or weight management.